Proton therapy for adult medulloblastoma: Acute toxicity and disease control outcomes
- 8 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Neuro-Oncology
- Vol. 153 (3), 467-476
- https://doi.org/10.1007/s11060-021-03783-x
Abstract
We report disease control, survival outcomes, and treatment-related toxicity among adult medulloblastoma patients who received proton craniospinal irradiation (CSI) as part of multimodality therapy.Keywords
This publication has 30 references indexed in Scilit:
- CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2011-2015Neuro-Oncology, 2018
- Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Neuro-Oncology, 2017
- Patterns of care in adult medulloblastoma: results of an international online surveyJournal of Neuro-Oncology, 2014
- Proton Beam Craniospinal Irradiation Reduces Acute Toxicity for Adults With MedulloblastomaInternational Journal of Radiation Oncology*Biology*Physics, 2013
- Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: A prospective observational multicentre studyEuropean Journal of Cancer, 2012
- The incidence of medulloblastomas and primitive neurectodermal tumours in adults and childrenJournal of Clinical Neuroscience, 2012
- Adult Medulloblastoma Comprises Three Major Molecular VariantsJournal of Clinical Oncology, 2011
- The treatment of adults with medulloblastoma: a prospective studyInternational Journal of Radiation Oncology*Biology*Physics, 2003
- Medulloblastoma: time–dose relationship based on a 30-year reviewInternational Journal of Radiation Oncology*Biology*Physics, 1998
- Treatment of Medulloblastoma in AdultsAmerican Journal of Clinical Oncology, 1992